The good, the bad, and the ugly: hyperprogression in cancer patients following immune checkpoint therapy

Published 2019 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
The good, the bad, and the ugly: hyperprogression in cancer patients following immune checkpoint therapy
Authors
Keywords
Immune checkpoint, Hyperprogression, Cancer, T cells, Antigen, Mutation
Journal
Genome Medicine
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-24
DOI
10.1186/s13073-019-0661-7
References
View 5 related references

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.